Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Healius Limited ( (AU:HLS) ) has shared an announcement.
Healius Limited announced the resignation of Steven Humphries as Company Secretary and the appointment of Andrew Thomson, the Chief Financial Officer, to the role effective October 29, 2025. This change in leadership is expected to streamline operations and maintain strong communication with the ASX, with Kylie Brown and Gillian Nairn continuing their roles in managing ASX-related communications.
The most recent analyst rating on (AU:HLS) stock is a Hold with a A$1.00 price target. To see the full list of analyst forecasts on Healius Limited stock, see the AU:HLS Stock Forecast page.
More about Healius Limited
Healius Limited is a leading healthcare company in Australia, dedicated to providing quality, affordable, and accessible healthcare services. With over 30 years of experience, Healius operates a wide network of centers and employs more than 8,500 staff to deliver specialty pathology services across the country.
Average Trading Volume: 4,869,731
Technical Sentiment Signal: Sell
Current Market Cap: A$595.4M
For detailed information about HLS stock, go to TipRanks’ Stock Analysis page.